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Prediction of Cardiovascular Events and
All-Cause Mortality With Arterial Stiffness
A Systematic Review and Meta-Analysis
Charalambos Vlachopoulos, MD, Konstantinos Aznaouridis, MD, Christodoulos Stefanadis, MD
Athens, Greece
Objectives The purpose of this study was to calculate robust quantitative estimates of the predictive value of aortic pulse
wave velocity (PWV) for future cardiovascular (CV) events and all-cause mortality by meta-analyses of longitudi-
nal studies.
Background Arterial stiffness is increasingly recognized as a surrogate end point for CV disease.
Methods We performed a meta-analysis of 17 longitudinal studies that evaluated aortic PWV and followed up 15,877
subjects for a mean of 7.7 years.
Results The pooled relative risk (RR) of clinical events increased in a stepwise, linear-like fashion from the first to the
third tertile of aortic PWV. The pooled RRs of total CV events, CV mortality, and all-cause mortality were 2.26
(95% confidence interval: 1.89 to 2.70, 14 studies), 2.02 (95% confidence interval: 1.68 to 2.42, 10 studies),
and 1.90 (95% confidence interval: 1.61 to 2.24, 11 studies), respectively, for high versus low aortic PWV sub-
jects. For total CV events and CV mortality, the RR was significantly higher in high baseline risk groups (coronary
artery disease, renal disease, hypertension) compared with low-risk subjects (general population). An increase in
aortic PWV by 1 m/s corresponded to an age-, sex-, and risk factor–adjusted risk increase of 14%, 15%, and
15% in total CV events, CV mortality, and all-cause mortality, respectively. An increase in aortic PWV by 1 SD
was associated with respective increases of 47%, 47%, and 42%.
Conclusions Aortic stiffness expressed as aortic PWV is a strong predictor of future CV events and all-cause mortality. The
predictive ability of arterial stiffness is higher in subjects with a higher baseline CV risk. (J Am Coll Cardiol
2010;55:1318–27) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.10.061(
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srterial stiffness is increasingly recognized as a surrogate
nd point for cardiovascular (CV) disease (1). Apart from
nvasive methods, it can also be measured with noninvasive,
eproducible, and relatively inexpensive techniques, and,
hus, it is suitable for large-scale studies. Arterial stiffness is
ssociated with presence of CV risk factors and atheroscle-
otic disease (1–7). Importantly, a number of studies exam-
ned the ability of arterial stiffness to predict the risk of future
atal and nonfatal CV events (myocardial infarction, stroke,
evascularization, stroke, aortic syndromes) and total mortality
8–32). Arterial elastic properties are increasingly used for risk
tratification purposes in several populations, and recently, the
uropean Society of Hypertension/European Society of Car-
iology guidelines for the management of arterial hypertension
uggested the measurement of aortic pulse wave velocity
rom the Peripheral Vessels Unit, 1st Department of Cardiology, Athens Medical
chool, Hippokration Hospital, Athens, Greece. Drs. Vlachopoulos and Aznaouridis
ontributed equally to this study.S
Manuscript received July 13, 2009; revised manuscript received September 28,
009, accepted October 12, 2009.PWV), which is considered the gold standard method for
ssessing aortic stiffness, as a tool for assessment of subclinical
arget organ damage (33).
Although there is a general impression that arterial stiffness
as an important predictive role based on the results of
ndividual studies (8–32), no overall quantitative estimate of
his role exists. Furthermore, the studies that investigated the
redictive role of arterial stiffness involved different popula-
ions. Moreover, the sizes of the populations studied were
ighly diverse and thus gave rise to dissimilar risk estimates. In
ddition, because most published studies yielded positive re-
ults, publication bias may have been involved. Finally, an
mportant issue is whether the predictive ability of arterial
tiffness extends beyond CV events. Accordingly, we con-
ucted the present systematic review and meta-analysis with
he aim to provide an overview of relevant studies and calculate
obust quantitative estimates of the predictive value of arterial
tiffness as expressed by aortic PWV for different outcomes
uch as total CV events, CV mortality, and all-cause mortality.
econd, we investigated whether publication bias could have
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March 30, 2010:1318–27 Arterial Stiffness and Clinical Eventsffected the true predictive ability of arterial stiffness. Third, we
valuated whether arterial stiffness portends a different predictive
bility in populations with different characteristics and estimated
aseline CV risk.
ethods
utcomes. The outcomes of interest were: 1) total CV
vents (CV deaths and nonfatal CV events [myocardial
nfarction, stroke, revascularization, aortic syndromes]); 2)
V mortality; and 3) total (all-cause) mortality.
tudy eligibility. Studies were deemed eligible if they: 1) were
ull-length publications in peer-reviewed journals; 2) evaluated
ortic PWV; 3) reported a combined CV outcome or CV
ortality or total mortality. No restriction criteria were im-
osed with regard to the type of the population studied
healthy subjects, general population, or populations with risk
actors or disease), the size of the population, or the duration of
ollow-up. All but one (25) of the longitudinal studies included
n the meta-analysis were prospective studies.
iterature search. Studies evaluating relationships of arte-
ial stiffness indexes with the risk of future clinical events
ere drawn from a systematic review of the English litera-
ure in the PubMed and Cochrane databases until February
010. The search terms were “stiffness,” “arterial stiffness,”
arterial elasticity,” or “pulse wave velocity,” and “predic-
ion,” “risk,” “death,” “mortality,” “outcome,” or “events.”
ata sources were also identified through manually search-
ng the references of articles.
xtraction of data. The literature search, selection of studies,
nd extraction of data was done independently by 2 reviewers
C.V., K.A.). Disagreements were resolved by consensus. For
ach study, we recorded a risk estimate for aortic PWV.
umeric data appearing in the articles were used. In a few
tudies not reporting these data, we calculated risk estimates
rom the survival curves.
tatistical analysis. The risk estimates of each study were
eported as a hazard ratio, relative risk (RR), odds ratio, or
ichotomous frequency data. We treated hazard ratios as RRs.
ecause no uniform cutoff values are available for aortic PWV,
atients were allocated to high stiffness group or low stiffness
roup according to cutoffs provided by each study (median,
pper tertile, optimal cutoff derived by receiver-operator char-
cteristic curve analysis or by an individually specified level of
ncrease) (Table 1). When available, we used the adjusted risk
stimates from multivariate models. To evaluate the shape
e.g., linear) of the association of aortic PWV with the risk of
linical events over the whole range of aortic PWV distribu-
ion, we calculated pooled RRs by tertiles of aortic PWV
8,13,19,23,25,28). The pooled RRs across the tertiles were
ompared using the nonparametric Friedman test.
We performed meta-analyses of studies measuring aortic
WV to obtain the pooled RRs separately for: 1) total CV
vents; 2) CV mortality; and 3) all-cause mortality. The
roportion of inconsistency across studies not explained by
hance was quantified with the I2 statistic. Heterogeneity between
ubgroups was calculated with Cochran’s Q test (34). When aignificant heterogeneity existed
mong studies, the random effects
odel was used to obtain the pooled
Rs. We also calculated adjusted
Rs per absolute PWV difference (1
/s and 1 SD) in addition to the
alculation of RR of high versus
ow stiffness groups in each study.
inally, we performed a sensitivity
nalysis to evaluate whether the
trength of risk estimates differs between high-risk groups
subjects with coronary artery disease, renal disease, hyperten-
ion, and diabetes) and low-risk groups (general population).
isk estimates between subgroups were compared with a test
f interaction (35). The RRs and confidence intervals (CIs) of
ndividual studies were illustrated with forest plots.
To estimate the contribution of continuous study mod-
rators to the overall heterogeneity, we ran a meta-
egression analysis with restricted maximum likelihood es-
imates. The presence of publication bias was investigated
raphically by funnel plots of precision, and its implications for
ur results were assessed by the Duval and Tweedie trim-and-
ll method (36) and the classic fail-safe N method. All analyses
ere performed with Comprehensive Meta Analysis Version 2
Biostat, Englewood, New Jersey) (37).
esults
ualitative summary. Our search identified 126 publica-
ions, which were narrowed by preliminary review to 40
otentially relevant original articles. Further, articles were
xcluded because of cross-sectional study design (n  5),
easurement of local aortic stiffness (n  4), and report of
nd points other than CV events or death (n 11). Twenty
tudies measuring aortic PWV were deemed eligible for our
eta-analysis (8–15,19–21,23–28,30–32) (Table 1). Three
f those studies (12,13,32) provided risk estimates from a
art of the population included in other studies (9,21) and
ere excluded from the main meta-analysis (high vs. low
tiffness). However, one of these studies (13) was included
n the evaluation of the shape (e.g., linear) of the association
f aortic PWV with risk (see section on the shape of the
ssociation between aortic PWV and clinical events) be-
ause, of the 3 studies (9,12,13), only this particular one (13)
rovided risk according to tertiles. Another article was also
xcluded because it presented results for PWV index (mea-
ured PWV minus theoretical PWV) (15) from the same
ohort as that in another article (8). Finally, our meta-
nalysis included 17 original articles assessing relationships
f aortic PWV with CV events, CV mortality, and all-cause
ortality. One study (31) presented separate data in men
nd women, so a total of 18 cohorts were included in the
eta-analysis. In total, the included studies analyzed 15,877
ubjects (the population of 1 study [13] was not added).
everal populations such as patients with hypertension,
iabetes, end-stage renal disease (ESRD), and coronary
Abbreviations
and Acronyms
CI  confidence interval
CV  cardiovascular
ESRD  end-stage renal
disease
PWV  pulse wave velocity
RR  relative riskrtery disease and subjects from the general population or
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Arterial Stiffness and Clinical Events March 30, 2010:1318–27thnic minorities are included. Details of the individual
tudies are shown in Table 1. All studies were published
ince 1999, and the mean/median follow-up ranged from
.5 years (10) to 19.6 years (28). The sample sizes ranged
rom 141 (10) to 2,835 (23) individuals.
Fourteen of the included studies assessed CV events
ncluding CV mortality (8 –11,19 –21,23–27,30,31). In
ost of those studies (n  11), CV mortality was separately
verview of Studies on the Association Between Aortic PWV and CTable 1 Overview of Studies on the Association Between Aorti
First Author,
Year (Ref. #)
Population
(Sample Size) Age (yrs) % Men
Follow-Up
Duration (yrs)
Anderson et al.,
2009 (28)
Nondiabetic general
population
(n  174)
60 10 51.1 19.6
Blacher et al.,
1999 (8)
ESRD (n  241) 51.5 16.3 61.0 6.0
Boutouyrie et al.,
2002 (13)*
Hypertension
(n  1,045)
51 12 65.0 5.7
Choi et al., 2007
(25)†
Chest pain patients
(n  497)
57.7 10.1 47.7 2.6
Cruickshank
et al., 2002
(14)
Diabetes (n  394) 60 10 60.0 10.7
Laurent et al.,
2001 (9)*
Hypertension
(n  1,980)
50 13 65.5 9.3
Mattace-Raso
et al., 2006
(23)
Community-based
adults
(n  2,835)
71.7 6.7 39.0 4.0–9.0
Meaume et al.,
2001 (10)
Subjects 70 yrs
(n  141)
87.1 6.6 27.0 2.5
Mitchell et al.,
2010 (30)
General population
(n  2,232)
63 12 42 7.8
Pannier et al.,
2005 (19)
ESRD (n  305) 53.1 16.2 62.0 5.8
Shoji et al.,
2001 (11)
ESRD (n  265) 55.4 10.5 41.0 5.3
Shokawa et al.,
2005 (20)
Ethnic minority
(n  492)
63.7 8.8 44.7 10.0
Sutton-Tyrrell
et al., 2005
(21)
Community-based
old adults
(n  2,488)
73.7 2.9 48.0 4.6
Terai et al.,
2008 (27)
Hypertension
(n  676)
62 12 55.0 4.8
Wang et al.,
2010 (31)
General population
(n  1,272)
52 13 53 15
Willum-Hansen
et al., 2006
(24)
General population
(n  1,678)
40–70 52.0 9.4
Zoungas et al.,
2007 (26)
ESRD (n  207) 55 13 67.6 3.6
Studies have a part of their population in common; the Laurent et al. (9) study (which is larger) w
ertiles) was used in the analysis for linear association between aortic PWV and clinical events. †
AA abdominal aorta; ABI ankle brachial index; BMI body mass index; BP blood pressure
learance; CRP  C-reactive protein; CV  cardiovascular; CVD  cardiovascular disease; ESRD
CC  intraclass correlation coefficient; IMT  intima-media thickness; LVH  left ventricul
OC  receiver-operator characteristic; TC  total cholesterol.ssessed. In 1 of those 11 studies (25), there were no CV teaths during the follow-up, so this study was not intro-
uced in the respective analysis. All-cause mortality was
valuated in 11 studies (8,9,11,14,20,21,23,25,27,28,31).
ge, sex, and other risk factors for CV disease were
ontrolled for in most of the studies (Table 1).
hape of the association between aortic PWV and clinical
vents. Nine studies provided data on the risk according to
trata of aortic PWV and allowed estimation of the shape of
l End PointsV and Clinical End Points
Events Modality Distance
deaths Doppler flow Sternoclavicular notch to
AA bifurcation
deaths, 48 CV deaths Doppler flow Aortic arch to FA
coronary events,
7 CV events,
Pressure transducer
(Complior)
CCA to FA
eath, no CV deaths,
20 CV events
Fluid-filled system (right
Judkins catheter)
Left subclavian artery to FA
deaths Doppler flow Sternoclavicular notch to
AA bifurcation
deaths, 46 CV deaths Pressure transducer
(Complior)
CCA to FA
deaths, 156 CV events Pressure transducer
(Complior)
CCA to FA
CV deaths Pressure transducer
(Complior)
CCA to FA
CV events Arterial tonometry Sternal notch to FA minus
sternal notch to CCA
CV deaths Pressure transducer
(Complior)
CCA to FA
deaths, 36 CV deaths PWV meter (PWV 200) Second intercostal sternal
edge to FA
deaths, 14 CV deaths Pressure transducer
(MCG400)
CCA to FA
deaths, 111 CV
eaths, 616 CV events
Doppler flow CCA to FA
deaths, 88 CV events Pressure transducer
(FCP-4731 device)
CCA to FA minus sternal
notch to CCA
deaths, 64 CV deaths Doppler flow Not reported
CV deaths,
54 CV events
Piezoelectric pressure
transducers (Hellige
GmbH)
CCA to FA
CV deaths, 65 CV events Pressure transducer
(Millar Mikro-tip,
SPT-301)
Sternal notch to FA minus
sternal notch to CCA
d for the analysis of high versus low stiffness and the Boutouyrie et al. (13) study (which provides
ective study.
common carotid artery; CI confidence interval; CoV coefficient of variation; CrCl creatinine
stage renal disease; FA  femoral artery; Hb  hemoglobin; HR  heart rate; Ht  hematocrit;
rtrophy; PP  pulse pressure; PWV  pulse wave velocity; RC  repeatability coefficient;linicac PW
58
73
53
9
1 d
1
179
107
352
27
151
96
81
43
265
d
22
225
62
1
17
as use
Retrosp
; CCA
 end-he association between aortic PWV and the risk of clinical
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March 30, 2010:1318–27 Arterial Stiffness and Clinical Eventsvents. A total of 6 studies (8,13,19,23,25,28) reported risk
ccording to tertiles, 3 studies reported risk according to
uartiles (21,27,30), and 1 study reported risk according to
uintiles (24) (Table 1). Analysis of the 6 studies reporting
ertiles showed that the pooled RRs increase in a stepwise,
inear-like fashion from the first to the third tertile (Fig. 1).
eta-analysis. We performed separate meta-analyses for
ach outcome (total CV events, CV mortality, and all-cause
ontinuedTable 1 Continued
Reproducibility
Aortic PWV in m/s
(Mean  SD)
Aortic PWV
(High vs.
PWV at baseline minus PWV at
1 month: 0.02 (95% CI:
0.06 to 0.03)
10.2 2.1 10.6 m/s (upper
intraobserver variability 5.8  1% 11.1 3.1 12.0 m/s (upper
Not reported 11.5 3.5 12.3 m/s (upper
Not reported Not reported 12.5 m/s (upper
PWV at baseline minus PWV
at 1 month: 0.02
(95% CI: 0.06 to 0.03)
11.6 3.8 3.8-m/s increase
Intraobserver RC 0.935
interobserver RC 0.890
11.5 3.4 5-m/s increase
Not reported 13.3 2.9 14.6 m/s in men
women (age-spe
tertile)
Reproducibility 8  1% 14.2 3.1 17.7 m/s (upper
Interobserver correlation
coefficient 0.972
9.3 (7.8–11.8)
median
(interquartile range)
9.3 m/s (median)
Not reported 11.1 3.1 Upper tertile
CoV 5% 8.6 2.2 8.2 m/s (median)
Not reported 9.7 1.9 9.9 m/s (optimal
ROC curve)
Between sonographers ICC 0.88
Between readers ICC 0.84
9.0 3.9 8.4 m/s in men; 
women (age-spe
Intraobserver CV 2.8  1.2% 9.0 0.6 8.8 m/s (median)
Not reported 9.5 2.3 (men)
9.5 2.5 (women)
2.3 m/s increase (m
2.5 m/s increase (w
Intraobserver RC 9% 11.3 3.4 13.1 m/s (upper
ICC 0.95 SD 3.5 9.9 m/s (cutoff)ortality). Pooled RRs for high versus low aortic PWV pere calculated. Furthermore, because our data indicated a
inear graded association of aortic PWV with clinical events
Fig. 1), we also calculated pooled RRs for increases in
ortic PWV per 1 m/s and 1 SD.
OTAL CV EVENTS. The magnitude of risk in individuals
ho had high aortic PWV was significantly higher com-
ared with the risk of individuals with low aortic PWV. The
ff
Aortic PWV Modeled in Adjusted for
Continuous, tertiles Age, sex
Continuous; tertiles Age, diastolic BP, sex, smoking, HR, Hb,
albumin, LVH, parathormone level,
antihypertensive drugs, time to
dialysis
Continuous; tertiles Framingham risk score
Tertiles Age, sex, diabetes, smoking,
hypertension, HR, PP, dyslipidemia
Continuous Age, systolic BP, sex, diabetes duration,
antihypertensive treatment
Continuous Age, previous CVD, diabetes, HR,
systolic BP, PP, sex, smoking,
hypercholesterolemia
2 m/s in
per
Tertiles Age, sex, mean BP, PP, HR, ABI,
carotid IMT
Continuous; upper decile Systolic and mean BP, previous CVD,
CrCl, autonomy in movement,
glucose, CRP, antihypert drugs,
nitrates
Continuous (inverse
transform aortic
PWV); quartiles
Age, sex, systolic BP, TC, high-density
lipoprotein cholesterol, smoking,
diabetes
Continuous; tertiles Age, PP, history of CVD, diabetes,
smoking
Continuous; median Age, sex, smoking, CRP, Ht, BMI,
diabetes, dialysis duration, creatinine,
systolic and diastolic BP, total protein
by Continuous; cutoff Age, sex, systolic BP, diabetes,
hypercholesterolemia
/s in
edian)
Continuous; quartiles Age, sex, race, systolic BP, CV disease,
creatinine, TC, HR, ABI0.9
Quartiles Age, sex, smoking, diabetes,
hyperlipidemia, systolic and diastolic
BP, creatinine
)
Continuous Unadjusted
) Continuous; quintiles Age, sex, BMI, mean BP, smoking,
alcohol intake
Continuous; cutoff Age, sex, systolic and diastolic BP,
diabetes, CVD history, TC, smoking,
carotid IMTCuto
Low)
tertile)
tertile)
tertile)
tertile)
; 14.
cific up
decile)
cutoff
7.9 m
cific m
en);
omen
quintileooled RRs for high aortic PWV were 2.26 (95% CI: 1.89
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Arterial Stiffness and Clinical Events March 30, 2010:1318–27o 2.70) for total CV events (Fig. 2A). The RR of total CV
vents for an increase in aortic PWV by 1 m/s was 1.14
95% CI: 1.09 to 1.20), corresponding to a risk increase of
4% (Fig. 3A). Furthermore, an increase in aortic PWV by
SD was associated with an RR of 1.47 (95% CI: 1.31 to
.64), corresponding to a risk increase of 47% (Fig. 4A).
Because we observed significant heterogeneity between
he included studies, we conducted between-study subgroup
nalyses to investigate its sources. The RR for high aortic
WV was higher in high-risk populations compared with
Figure 1
Box and Whisker Plot of Pooled Relative Risk
(Log) of Clinical Events by Tertiles of Aortic
Pulse Wave Velocity From 6 Studies
Data from 6 studies (8,13,19,23,25,28). The center line of the box denotes
the median value, the extremes of the box, the interquartile range, and the
bars, the upper and lower limits of 95% of the data. p value by Friedman test.
Figure 2 RR and 95% CI for High Aortic PWV and Clinical Even
Relative risk (RR) and 95% confidence interval (CI) for high aortic pulse wave velocity (
(C). Studies are listed alphabetically. Boxes represent the RR and lines represent the
the 95% CI, respectively. CAD  coronary artery disease; DM  diabetes mellitus; ESow-risk populations (RR: 2.44; 95% CI: 2.01 to 2.97 vs.
R: 1.68, 95% CI: 1.45 to 1.96, respectively; p  0.003)
Fig. 5A). The difference of RR per 1-m/s increase and per
-SD increase was not statistically significant (Fig. 5A).
urthermore, in a population-specific analysis, we found
hat the RR for high aortic PWV showed a significant
ncrease in ESRD groups and in hypertension groups
ompared with general population groups (RR: 2.81, 95%
I: 1.97 to 4.02 in ESRD groups vs. RR: 2.46, 95% CI:
.93 to 3.13 in hypertension groups vs. RR: 1.68, 95% CI:
.45 to 1.96 in general population groups; p  0.01 for
SRD vs. general population groups and p  0.009 for
ypertension groups vs. general population groups).
V MORTALITY. The pooled RRs of CV mortality were
igher for high aortic PWV compared with low aortic PWV
ubjects (RR: 2.02, 95% CI: 1.68 to 2.42) (Fig. 2B). The RRs
f CV mortality for an increase in aortic PWV by 1 m/s and 1
D were 1.15 (95% CI: 1.09 to 1.21) and 1.47 (95% CI: 1.29
o 1.66) (Figs. 3B and 4B), corresponding to a risk increase of
5% and 47%, respectively. The RR for high aortic PWV was
igher in high-risk populations compared with low-risk pop-
lations (RR: 2.48; 95% CI: 1.94 to 3.18 vs. RR: 1.68, 95% CI:
.41 to 2.01, respectively; p  0.013) (Fig. 5B).
LL-CAUSE MORTALITY. The pooled RRs of all-cause mor-
ality were higher for high aortic PWV compared with
ow-stiffness subjects (RR: 1.90, 95% CI: 1.61 to 2.24) (Fig.
C). Overall, the RRs of all-cause mortality for an increase
n aortic PWV by 1 m/s and 1 SD were 1.15 (95% CI: 1.09
o 1.21) and 1.42 (95% CI: 1.29 to 1.58) (Figs. 3C and 4C),
nd total cardiovascular (CV) events (A), CV mortality (B), and all-cause mortality
I for individual studies. The diamonds and their width represent the pooled RRs and
end-stage renal disease; GEN  general population; HTN  hypertension.ts
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95% C
RD 
c
t
i
g
C
E
M
a
s
t
p
s
a
w
f
i
p
n
1323JACC Vol. 55, No. 13, 2010 Vlachopoulos et al.
March 30, 2010:1318–27 Arterial Stiffness and Clinical Eventsorresponding to a risk increase of 15% and 42%, respec-
ively. The RR for high aortic PWV was nonsignificantly
ncreased in high-risk groups compared with low-risk
roups (RR: 2.43, 95% CI: 1.58 to 3.73 vs. RR: 1.66, 95%
I: 1.46 to 1.88; p  0.098) (Fig. 5C), and especially in
SRD patients (RR: 3.05, 95% CI: 1.34 to 6.98).
eta-regression analysis. We performed a meta-regression
nalysis to estimate the impact of continuous study moderators
uch as age, duration of follow-up, and baseline aortic PWV on
Figure 3 RR and 95% CI for a 1-m/s Increase in Aortic PWV an
RR and 95% CI for a 1-m/s increase in aortic PWV and total CV events (A), CV mo
and all-cause mortality (C). Studies are listed alphabetically. Symbols and abbrevi
Figure 4 RR and 95% CI for a 1-SD Increase in Aortic PWV and
RR and 95% CI for a 1-SD increase in aortic PWV and total CV events (A), CV mor
and all-cause mortality (C). Studies are listed alphabetically. Symbols and abbrevihe overall heterogeneity. Age at enrollment was the strongest
redictor of the magnitude of the log RR for outcomes in
ubjects with high aortic PWV, but there were differences
ccording to the group of patients studied. In particular, age
as inversely related to the predictive role of high aortic PWV
or CV mortality only in ESRD patients (8,11,19,26) (Fig. 6),
ndicating that aortic PWV is a stronger determinant of
rognosis in younger ESRD patients. In contrast, there was
o relationship of age and the predictive role of aortic PWV
nical Events
(B),
as in Figure 2.
ical Events
B),
as in Figure 2.d Cli
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Arterial Stiffness and Clinical Events March 30, 2010:1318–27n hypertensive patients and in the general population
ubjects, indicating that stiffness retains its predictive ability
ndependently of age in those groups. There were no
onsistent strong relationships between the predictive ca-
acity of high aortic PWV and the duration of follow-up or
he value of aortic PWV at enrollment.
ublication bias. STUDIES RELATING AORTIC PWV WITH
OMPOSITE CV OUTCOMES (14 STUDIES, 15 COHORTS). The
unnel plot was asymmetrical at the bottom (Fig. 7A, top),
uggesting an absence of small studies with small or negative
isk estimates in our meta-analysis, either because of publica-
ion bias or because of a true inexistence of negative studies
absence of publication bias). The trim-and-fill method im-
Figure 5 Pooled RR and 95% CI for Aortic PWV and Clinical Ev
Pooled RR and 95% CI for aortic PWV and total CV events (A), CV mortality (B), an
includes studies in general population. All the other populations (see Methods) ar
wave velocity (PWV) (left column), increase in aortic PWV by 1 m/s (middle colum
Figure 6 RR of CV Mortality in Patients With
High Aortic PWV and ESRD as a Function of Age
Data from 4 studies (8,11,19,26). The size of the data markers relates to the
weight of each study. Abbreviations as in Figure 2.euted missing studies and recalculated our pooled risk estimate
Fig. 7A, bottom). The imputed RR was 1.71 (95% CI: 1.42
o 2.05), which is lower than our original risk estimate but is
till a significant one. Importantly, the result of the fail-safe N
est of our pooled analysis is 1,542, which is reassuring. The
ail-safe N test computes the number of missing studies (with
mean effect of zero) that would need to be added to the
nalysis to yield a statistically nonsignificant overall effect, and
t is very unlikely that there are more than 102 (1,542/15 
02.8) unpublished or undiscovered studies for every 1 study
hat we found. These findings suggest that the apparent publica-
ion bias is insufficient to affect our results or interpretations in a
eaningful way.
TUDIES RELATINGAORTIC PWVWITHALL-CAUSEMORTALITY
11 STUDIES, 12 COHORTS). Similarly, the funnel plot was
symmetric at the bottom (Fig. 7B, top). The trim-and-fill
ethod showed an imputed RR of 1.65 (95% CI: 1.36 to
.99) (Fig. 7B, bottom), which remains significant. The
esult of the fail-safe N test of our pooled analysis is 719,
hich is reassuring because it is very unlikely that there are
ore than 59 (719/12  59.9) unpublished or undiscovered
tudies for every 1 study that we found.
iscussion
n this systematic review and meta-analysis, we pooled
he aortic PWV data for 15,877 subjects from 17 avail-
ble published studies who were followed up for a mean
f 7.7 years. Within each patient group, the risk of CV
According to Baseline Risk
l mortality (C), according to baseline risk and disease state. The low-risk group
ded in the high-risk group. Data are provided for high versus low aortic pulse
d increase in aortic PWV by 1 SD (right column).ents,
d tota
e inclu
n), anvents, CV mortality, and all-cause mortality in subjects
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March 30, 2010:1318–27 Arterial Stiffness and Clinical Eventsith increased aortic PWV, which is considered as the
old standard index of aortic stiffness, is almost twice as
igh compared with the risk of subjects with lower aortic
WV. Importantly, the predictive value of increased
rterial stiffness is larger in patients with higher risk
isease states, such as renal disease. Although for each
atient group exact values may differ slightly, for an
ncrease in aortic PWV of 1 m/s or of 1 SD, the risk
ncreases by more than 10% or 40%, respectively.
Although some narrative reviews supporting the predictive
ole of arterial stiffness have been published to date (including
he European guidelines for arterial hypertension that sug-
ested aortic PWV as a tool for assessment of subclinical target
rgan damage) (1,2,4–7,33), the present study is the first
eta-analysis to provide robust pooled estimates of this role.
n important strength of our study is the exhaustive search
trategy that likely enabled us to capture most, if not all,
elevant studies. Furthermore, as a meta-analysis, the present
tudy overcomes the potentially biased inclusion and weighing
f results that may appear in reviews when interpreting the
vailable evidence. Furthermore, we dealt with potential pub-
ication bias. The fact that there are not many published studies
ith negative results may be due to a true “universal” predictive
ole of aortic PWV or may reflect publication bias. Even if the
atter is the case, our analysis (using 2 approaches, the trim-
nd-fill and fail-safe N methods) indicates that any publication
ias may have accounted only for a slight overestimation of a
Figure 7 Publication Bias for Total CV Outcomes and All-Cause
(A) Total CV outcomes; (B) all-cause mortality. The open circles in the top and bo
and the open diamonds are the RR and 95% CI for the meta-analysis. The solid ci
RR and 95% CI for the meta-analysis after adjusting for publication bias. Abbreviatrue predictive role of aortic PWV for clinical outcomes. aThe predictive value of arterial stiffness is based on its patho-
hysiological importance for arterial and overall CV performance
1–5). Large artery stiffening increases left ventricular afterload
1,3) and is associated with left ventricular hypertrophy (38) and
mpaired coronary perfusion (3,39,40). Thus, the coronary perfu-
ion/myocardial demand equilibrium is unbalanced. Furthermore,
tiffening of large arteries is involved in the pathogenesis of
ypertension (1–5). Our analysis demonstrated that aortic PWV
as predictive value independent of classic CV risk factors and
ther potential confounders. This indicates that arterial stiffness
ay integrate not only the effect of the genetic background (41)
ut also of the cumulative damage of CV risk factors on the
rterial wall over a long period of time, whereas the individual risk
actors can fluctuate over time and their values, recorded at the
ime of risk assessment, may not reflect their true impact on the
rterial wall. Aortic PWV may represent a surrogate end point,
hich may in fact indicate in which patients the traditional CV
isk factors translate into real risk.
Our findings are potentially applicable to clinical practice.
irst, they justify inclusion of arterial stiffness by European
uidelines for arterial hypertension and suggest extension to
ther disease states or population groups. Our analysis showed
hat the risk associated with increased arterial stiffness is similar
o the risk of established risk predictors commonly used in
linical practice, such as left ventricular hypertrophy (42,43).
urthermore, an important finding of our analysis is that
rterial stiffness is a powerful predictor of all-cause mortality in
tality and Its Potential Impact
plots represent individual studies relating aortic pulse wave velocity with events,
n the bottom plots represent imputed studies, and the solid diamonds are the
s in Figure 2.Mor
ttom
rcles i
ions addition to CV outcomes. Interestingly, CV mortality ac-
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Arterial Stiffness and Clinical Events March 30, 2010:1318–27ounted only for 50% to 55% of cases of all-cause mortality in
he included studies (Table 1). Although pathophysiological
xplanations are not readily identifiable, this could reflect the
xistence of common pathogenetic mechanisms, such as aging,
nflammation, and oxidative stress, over a wide range of
onditions. Improvement of arterial stiffness per se is beneficial
n terms of prognosis in high-risk groups (44), and our results
ighlight the role of arterial stiffness as a potential treatment
arget in broader patient groups. Further dissection of our
rincipal finding provided interesting information. Because the
opulations of the enrolled studies differed with respect to
aseline CV risk, population size, age distribution, and length
f follow-up, we investigated the role of these factors by
eparate meta-analyses and by meta-regression analysis. Our
nalysis indicates that aortic PWV has a better ability to predict
dverse outcomes in subjects with higher baseline CV risk
patients with coronary artery disease, renal disease, hyperten-
ion, or diabetes) than in subjects with presumably lower risk
general population). Although there was no difference in risk
rediction/estimates in relation to age in hypertensive patients
r in general population subjects, there was a better predictive
bility of stiffness for clinical events in younger ESRD patients.
xplanations for the latter may include a “selection” phenom-
non, with ESRD survivors who reach an older age being less
ulnerable to the harmful effects of arterial stiffening. It should
e noted, however, that because the statistical power of our
eta-regression analyses in most groups of patients was limited
ue to the small number of available studies, the present data
ay underestimate the discriminative ability of stiffness in
ome populations, and clearly there is need for further studies.
Our study provides interesting caveats with regard to the
eterogeneity of methods used across studies measuring aortic
WV. For example, there is no universal consensus on which
istance should be introduced in the PWV equation for calcula-
ions. Although some studies subtract the carotid-sternal distance
rom the carotid-femoral distance or the sternal-femoral distance
o account for the opposite direction of flow (26,27,30), Table 1
hows that most studies use the whole distance between the 2 sites
f measurement, thus leading to an overestimation of true wave
elocity measured directly with invasive methods (45). Although
ll approaches are approximations without important impact in
ntervention studies with repeated measurements, when compar-
ng populations or pooling data from different studies, differences
n the methods used to assess the path length may be important
1). Less than one-half of the studies that we included adjusted for
eart rate (Table 1), which determines both CV outcomes and
WV. Many studies adjusted for body mass index or weight
Table 1) because these metrics relate to both PWV and CV
vents. However, adjusting for waist circumference would provide
erhaps more insights because this would also control for a
otential overestimation of the carotid-femoral path across an
nlarged abdomen in obese individuals. Accordingly, a consensus
s necessary on these issues so that future studies use uniform
echniques and analytical approaches. This will facilitate between-
tudies comparison and definition of cutoff values in different
opulations and will further promote the implementation of aortic
WV in everyday clinical practice. Furthermore, as aortic PWV ishe best documented and most widely used marker of arterial
tiffness to date, standardization of its measurement will also
acilitate comparability and validation of other emerging stiffness
ndexes.
tudy limitations. In this analysis, we used aggregate data
s reported in published articles (or calculated from other
ata provided in the articles) rather than data for individual
atients. Accordingly, we did not deal with potential meth-
dological problems of the original studies. Furthermore,
he ability of aortic PWV to discriminate, calibrate, and
eclassify risk could not be assessed. Only 2 of the included
tudies (23,30) provided robust estimates of the discrimina-
ory power of aortic PWV beyond classic risk factors or
easures of subclinical atherosclerosis. Second, to define
igh and low stiffness, we used the cutoff values used by each
tudy because there are no established cutoffs for stiffness
easurements. This may have theoretically introduced a
ias factor. Reference values and cutoff points are important
lements for clinical integration of arterial stiffness, and
part from published data (46–48), further studies are
nder way (49). Although the robustness of our principal
nding (that aortic PWV is an important risk predictor) is
ignificantly reinforced by the clear relationship of aortic
WV as a continuous variable (1-m/s or 1-SD increase)
ith all 3 outcomes, independent of all important con-
ounders, we cannot with certainty rule out the role of
esidual confounding. Furthermore, our meta-regression
ndings may be limited by the small number of available
tudies. Finally, although CV mortality and all-cause mor-
ality were uniformly defined, the definition of total CV
vents differed among the studies included in analysis.
onclusions
ortic PWV is a strong predictor of future CV events and
ll-cause mortality. The predictive ability of arterial stiffness is
igher in subjects with a higher baseline CV risk. These
ndings support implementation of aortic PWV into clinical
ractice and stress the need to establish reference values.
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